リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Relationship between a high Edinburgh Postnatal Depression Scale score and premenstrual syndrome: A prospective, observational study」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Relationship between a high Edinburgh Postnatal Depression Scale score and premenstrual syndrome: A prospective, observational study

Takayama Erina 三重大学

2021.01.05

概要

Objective: This study aimed to evaluate whether the Edinburgh Postnatal Depression Scale (EPDS) score predicts the occurrence of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD)after delivery.
Materials and methods: The women in this study were registered at 35-36 weeks of pregnancy at Mie University Hospital from 2013 to 2015. We prospectively divided the puerperants into those with an EPDS score >9 (the high-EPDS group) and those with an EPDS score <9 (the low-EPDS group) at 1 month postpartum. We compared the incidence rate of severe PMS and PMDD between both groups at 1 year after delivery.
Results: Of 200 registered cases, 178 (89.0%) did not experience severe PMS or PMDD before pregnancy. Among them, 21 were in the high-EPDS group, and 89 in the low-EPDS group. Four of the 21 women (19.0%) in the high-EPDS group and five of the 89 (5.6%) in the low-EPDS group had severe PMS or PMDD at 1 year after delivery. The incidence rate of severe PMS or PMDD in the high-EPDS group was higher than that in the low-EPDS group (p = 0.07).
Conclusions: The novel finding of this study is that the EPDS may predict the occurrence of severe PMS/PMDD after delivery. The EPDS will contribute to the early detection of these diseases and to improving the quality of life of the patients by allowing treatment initiation at an early stage.

参考文献

[1] Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA. Pretreatment pattern of

symptom expression in premenstrual dysphoric disorder. J Affect Disord

2005;85:275e82.

[2] Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression

across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci 2008;33:331e43.

[3] Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening

tool (PSST) for clinicians. Arch Womens Ment Health 2003;6:203e9.

[4] Wittchen HU, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of

premenstrual dysphoric disorder in the community. Psychol Med 2002;32:

119e32.

[5] Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, et al. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebocontrolled, clinical trial using computerized diaries. Obstet Gynecol

2002;100:435e44.

[6] Sternfeld B, Swindle R, Chawla A, Long S, Kennedy S. Severity of premenstrual

symptoms in a health maintenance organization population. Obstet Gynecol

2002;99:1014e24.

[7] Dennerstein L, Lehert P, Heinemann K. Epidemiology of premenstrual symptoms and disorders. Menopause Int 2012;18(2):48e51.

[8] Lee YJ, Yi SW, Ju DH, Lee SS, Sohn WS, Kim IJ. Correlation between postpartum

depression and premenstrual dysphoric disorder: single center study. Obstet

Gynecol Sci 2015;58:353e8.

[9] Buttner MM, Mott SL, Pearlstein T, Stuart S, Zlotnick C, O'Hara MW. Examination of premenstrual symptoms as a risk factor for depression in postpartum women. Arch Womens Ment Health 2013;16:219e25.

[10] Keppel AL, Lee EE, Haq N, Rubinow DR, Schmidt PJ. History of postpartum

depression in a clinic-based sample of women with premenstrual dysphoric

disorder. J Clin Psychiatry 2016;77. e4 15-20.

[11] Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry

1987;150:782e6.

[12] Okano T, Murata M, Masuji F, Tamaki R, Nomura J, Miyaoka H, et al. Validation

and reliability of Japanese version of the EPDS. Arch Psychiatr Diagn Clin Eval

1996;7:525e33 [published in Japanese].

[13] Bloch M, Rotenberg N, Koren D, Klein E. Risk factors associated with the

development of postpartum mood disorders. J Affect Disord 2005;88:9e18.

[14] Bloch M, Rotenberg N, Koren D, Klein E. Risk factors for early postpartum

depressive symptoms. Gen Hosp Psychiatry 2006;28:3e8.

[15] Bloch M, Daly RC, Rubinow DR. Endocrine factors in the etiology of postpartum depression. Compr Psychiatry 2003;44:234e46.

[16] Klink R, Robichaud M, Debonnel G. Gender and gonadal status modulation of

dorsal raphe nucleus serotonergic neurons. Part I: effects of gender and

pregnancy. Neuropharmacology 2002;43:1119e28.

[17] Sacher J, Wilson AA, Houle S, Rusjan P, Hassan S, Bloomfield PM, et al. Elevated

brain monoamine oxidase A binding in the early postpartum period. Arch Gen

Psychiatry 2010;67:468e74.

[18] Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness

and treatment update. J Psychiatry Neurosci 2008;33:291e301.

[19] Ryu A, Kim TH. Premenstrual syndrome: a mini review. Maturitas 2015;82:

436e40.

[20] Perkonigg A, Yonkers KA, Pfister H, Lieb R, Wittchen HU. Risk factors for

premenstrual dysphoric disorder in a community sample of young women:

the role of traumatic events and posttraumatic stress disorder. J Clin Psychiatry 2004;65:1314e22.

[21] Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older

premenopausal women. The Harvard Study of Moods and Cycles. J Affect

Disord 2002;70:125e32.

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る